Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Filings indexed 725 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country KR South Korea
Listing KO 007460

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2026-05-08 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2026-05-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.